Change language to Arabic Change language to Chinese (Simplified) Change language to Dutch Change language to English Change language to French Change language to German Change language to Italian Change language to Japanese Change language to Portuguese Change language to Russian Change language to Spanish

News | 1 min read

Developer of concussion test raises $23m to further clinical trials

December 9, 2020

A Richmond-based company that has developed a medical test to assist with the diagnosis and prognosis of concussions has attracted $23 million from investors to help advance its research.

BrainBox Solutions announced it had closed on a $23 million Series A financing round — the company’s largest-ever investment round — to support the clinical development of the company’s test for mild Traumatic Brain Injury, or TBI, which can affect more than 5 million people a year and cause long-term cognitive problems.

BrainBox is based in the Virginia Bio+Tech Research Park in downtown Richmond. The startup company was spun off in 2018 as a separate business from ImmunArray, another biotech firm in Richmond that developed a proprietary test to rule out the presence of the autoimmune disease lupus in blood samples.

The TBI test developed by BrainBox uses several inputs to assess a brain injury, including a panel of blood biomarkers as well as neurocognitive testing. The company is working in partnership with BrainCheck Inc., based in Houston, Texas, on those tests.

Read the full story here.